Skip to main content

WHO Leads in Using Solid Science to Draft COVID-19 Policy: Study

Governments are variable in their reliance on highly cited research, while international intergovernmental organizations such as the World Health Organization reliably link policy and science, according to an analysis of thousands of policy documents from the first half of 2020.

Written byMax Kozlov
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

ABOVE: The World Health Organization (WHO) headquarters in Geneva, Switzerland
© ISTOCK.COM, OLRAT

As the COVID-19 pandemic has unfolded, scientific experts and policymakers have had to work together closely to keep up with the latest science and implement policies to prevent further transmission of the virus. Meanwhile, the pace at which COVID-19 research has been published has led misinformation to spread rampantly, sometimes working its way into the upper echelons of government.

To see how well policymakers worldwide incorporated solid COVID-19 research into their decisions, researchers examined scientific citations within 37,725 policy documents spanning 114 countries and 55 intergovernmental organizations that were drafted between early January and late May of last year. In a study published in Science yesterday (January 7), they found that these documents referenced COVID-19 papers that had, on average, 40 times more citations than other COVID-19 papers. Peer-reviewed papers from leading scientific journals were far more represented ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Max is a science journalist from Boston. Though he studied cognitive neuroscience, he now prefers to write about brains rather than research them. Prior to writing for The Scientist as an editorial intern in late 2020 and early 2021, Max worked at the Museum of Science in Boston, where his favorite part of the job was dressing in a giant bee costume and teaching children about honeybees. He was also a AAAS Mass Media Fellow, where he worked as a science reporter for the St. Louis Post-Dispatch. Read more of his work at www.maxkozlov.com.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays